Ticker Scorecard - VTGN Basics Company: VistaGen Therapeutics, Inc. IPO Date: July 1, 2011 Sector: Healthcare Industry: Biotech Market Cap: $84.57M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 4.07% Avg Daily Range (30 D): $0.07 | 2.33% Avg Daily Range (90 D): $0.08 | 2.79% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .22M Trade Size Avg Trade Size (Sh.): 43 Avg Trade Size (Sh.) (30 D): 153 Avg Trade Size (Sh.) (90 D): 176 Institutional Trades Total Inst.Trades: 81 Avg Inst. Trade: $2.06M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $1.19M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.82M Avg Closing Trade (30 D): $.76M Avg Closing Trade (90 D): $.76M Avg Closing Volume: 147.97K     News Sep 6, 2024 @ 7:52 PM All You Need to Know About VistaGen Therapeutics R... Source: Zacks Feb 21, 2024 @ 2:55 PM Does VistaGen Therapeutics, Inc. (VTGN) Have the P... Source: Zacks Equity Research Feb 1, 2024 @ 10:16 AM Immunocore Holdings PLC Sponsored ADR (IMCR) Moves... Source: Zacks Equity Research Dec 29, 2023 @ 1:40 PM How Vistagen (VTGN) Stock Stands Out in a Strong I... Source: Zacks Equity Research Dec 4, 2023 @ 7:39 PM Undervalued VistaGen Therapeutics, Analyst Highlig... Source: Vandana Singh Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.46 $-.42 $-.35 Diluted EPS $-.46 $-.42 $-.35 Revenue $ .23M $ .18M $ .08M Gross Profit $ $ $ Net Income / Loss $ -14.09M $ -12.96M $ -10.73M Operating Income / Loss $ -15.12M $ -14.23M $ -12.13M Cost of Revenue $ $ $ Net Cash Flow $ -9.53M $ -18.67M $ -16.25M PE Ratio     Splits Jun 07, 2023:   30:1 Aug 14, 2014:   20:1 Jun 10, 2011:   1:2